Equities

Medirom Healthcare Technologies Inc

MRM:NAQ

Medirom Healthcare Technologies Inc

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (USD)5.01
  • Today's Change-0.079 / -1.56%
  • Shares traded714.00
  • 1 Year change-10.22%
  • Beta0.0355
Data delayed at least 15 minutes, as of Jun 14 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

  • Revenue in USD (TTM)26.13m
  • Net income in USD-3.93m
  • Incorporated2000
  • Employees171.00
  • Location
    Medirom Healthcare Technologies Inc16F, Tradepia Odaiba, 2-3-1, DaibaMINATO-KU 135-0091JapanJPN
  • Phone+81 367217364
  • Fax+81 367217365
  • Websitehttps://medirom.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Clearday Inc7.54m-21.54m13.52m225.00------1.79-0.9722-0.99380.3147-1.700.3432--201.6333,524.13-77.04-71.37---342.36-----224.52-205.25---0.9413-----3.0594.7325.38---28.32--
Univec Inc-100.00bn-100.00bn13.62m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
PharmChem Inc6.04m722.90k14.55m170.0021.456.9820.122.410.14590.14591.220.44851.797.6210.04--21.47--25.28--65.12--11.96--3.98------3.50---16.95------
Kindly MD Inc3.77m-1.62m16.04m23.00------4.26-0.2709-0.27090.6311-0.0182------163,852.60--------94.00---42.92--0.6799-29.021.40---0.488--36.34------
Novo Integrated Sciences Inc13.66m-12.08m17.03m127.00--0.7147--1.25-0.7517-0.75170.85841.250.38248.708.88107,543.60-33.86-29.43-43.28-35.6440.3539.59-88.55-110.250.4089-3.980.1305--7.117.1759.77---22.73--
ATI Physical Therapy Inc713.56m-119.67m18.43m6.00k------0.0258-28.91-28.91171.8125.330.7005--7.81118,926.00-5.34---6.12--15.64---7.62-----0.10110.8274--9.97--73.20------
Pacific Green Technologies Inc89.10m7.88m21.99m45.002.881.332.750.24680.14580.14581.810.31541.99--53.471,979,898.0015.61-12.0348.16-46.7827.5339.687.85-13.35---0.60590.122---50.5230.80-5.25---73.45--
Healthlynked Corp4.97m-3.82m23.06m38.00--105.43--4.64-0.0142-0.01430.01850.00080.990713.4033.09130,827.90-76.20-119.37-189.55-332.2255.6655.81-76.92-119.260.6532--0.8047---2.3220.4357.08---12.94--
Medirom Healthcare Technologies Inc(ADR)26.13m-3.93m24.41m171.00--18.64--0.9339-0.9481-0.94815.880.26820.8847406.6210.40152,834.50-13.29---25.58--17.03---15.03--0.3519-53.290.7856---14.50---3,210.30------
Aesthetic Medical Intl Hldg Grp Ltd(ADR)94.08m-5.16m25.18m1.29k--3.747.030.2677-0.1176-0.11762.210.1411.2316.6085.1473,153.94-7.21-23.36-44.53-48.5847.1855.32-5.85-23.720.2333-3.700.8791--1.86-2.1650.91--3.70--
Concord Medical Services Hldgs Ltd (ADR)74.07m-41.02m25.86m727.00------0.3491-0.9391-0.93911.70-6.740.08919.815.27101,879.20-8.81-9.49-85.81-39.24-14.26-15.06-98.81-134.560.2956-5.700.6348--13.8423.0039.21---6.88--
Nutex Health Inc258.77m-41.00m26.81m800.00--0.4255--0.1036-0.9175-0.91755.711.270.620367.704.41323,463.30-8.88-69.35-10.70-84.8515.4910.97-14.32-102.851.630.24890.7617--12.93428.2289.22------
Oncology Institute Inc342.71m-59.65m33.50m800.00--0.8098--0.0977-0.8066-0.80664.630.55571.5626.166.55428,391.30-33.23---40.16--16.7619.54-21.29-9.992.83-7.940.6816--28.4223.43-99,919.12--45.68--
Exagen Inc55.73m-19.36m34.05m174.00--1.70--0.611-1.09-1.093.131.150.8572--5.52320,304.60-29.78-30.21-34.58-33.7558.7654.86-34.74-55.36---8.070.4998--15.3310.1350.01--33.00--
Data as of Jun 14 2024. Currency figures normalised to Medirom Healthcare Technologies Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.